Literature DB >> 36162590

Reappraisal of Coronavirus Disease 2019 Risk for Patients with Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid.

Ryan C Ungaro1, Michael D Kappelma2.   

Abstract

Entities:  

Year:  2022        PMID： 36162590      PMCID： PMC9514020          DOI： 10.1053/j.gastro.2022.09.015

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   33.883


× No keyword cloud information.
  19 in total

1.  Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis.

Authors:  Yousaf Hadi; Parambir S Dulai; Justin Kupec; Nabeeha Mohy-Ud-Din; Vipul Jairath; Francis A Farraye; Gursimran S Kochhar
Journal:  Aliment Pharmacol Ther       Date:  2021-12-14       Impact factor: 8.171

2.  Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients.

Authors:  Amanda Ricciuto; Christopher A Lamb; Eric I Benchimol; Gareth J Walker; Nicholas A Kennedy; M Ellen Kuenzig; Gilaad G Kaplan; Michael D Kappelman; Ryan C Ungaro; Jean-Frederic Colombel; Erica J Brenner; Manasi Agrawal; Walter Reinisch; Anne M Griffiths; Shaji Sebastian
Journal:  J Crohns Colitis       Date:  2022-05-10       Impact factor: 10.020

3.  Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study.

Authors:  Antoine Meyer; Laura Semenzato; Mahmoud Zureik; Alain Weill; Franck Carbonnel; Rosemary Dray-Spira
Journal:  Aliment Pharmacol Ther       Date:  2021-06-10       Impact factor: 8.171

4.  Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.

Authors:  Erica J Brenner; Ryan C Ungaro; Richard B Gearry; Gilaad G Kaplan; Michele Kissous-Hunt; James D Lewis; Siew C Ng; Jean-Francois Rahier; Walter Reinisch; Frank M Ruemmele; Flavio Steinwurz; Fox E Underwood; Xian Zhang; Jean-Frederic Colombel; Michael D Kappelman
Journal:  Gastroenterology       Date:  2020-05-18       Impact factor: 22.682

5.  British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.

Authors:  Nicholas A Kennedy; Gareth-Rhys Jones; Christopher A Lamb; Richard Appleby; Ian Arnott; R Mark Beattie; Stuart Bloom; Alenka J Brooks; Rachel Cooney; Robin J Dart; Cathryn Edwards; Aileen Fraser; Daniel R Gaya; Subrata Ghosh; Kay Greveson; Richard Hansen; Ailsa Hart; A Barney Hawthorne; Bu'Hussain Hayee; Jimmy K Limdi; Charles D Murray; Gareth C Parkes; Miles Parkes; Kamal Patel; Richard C Pollok; Nick Powell; Chris S Probert; Tim Raine; Shaji Sebastian; Christian Selinger; Philip J Smith; Catherine Stansfield; Lisa Younge; James O Lindsay; Peter M Irving; Charlie W Lees
Journal:  Gut       Date:  2020-04-17       Impact factor: 23.059

6.  Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.

Authors:  Nicholas A Kennedy; James R Goodhand; Nicholas Powell; Tariq Ahmad; Claire Bewshea; Rachel Nice; Desmond Chee; Simeng Lin; Neil Chanchlani; Jeffrey Butterworth; Rachel Cooney; Nicholas M Croft; Ailsa L Hart; Peter M Irving; Klaartje B Kok; Christopher A Lamb; Jimmy K Limdi; Jonathan Macdonald; Dermot Pb McGovern; Shameer J Mehta; Charles D Murray; Kamal V Patel; Richard Cg Pollok; Timothy Raine; Richard K Russell; Christian P Selinger; Philip J Smith; Jack Bowden; Timothy J McDonald; Charlie W Lees; Shaji Sebastian
Journal:  Gut       Date:  2021-03-22       Impact factor: 31.793

7.  Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases.

Authors:  Millie D Long; Kimberly N Weaver; Xian Zhang; Kelly Chun; Michael D Kappelman
Journal:  Clin Gastroenterol Hepatol       Date:  2022-02-09       Impact factor: 13.576

8.  Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.

Authors:  Tommy Nyberg; Neil M Ferguson; Sophie G Nash; Harriet H Webster; Seth Flaxman; Nick Andrews; Wes Hinsley; Jamie Lopez Bernal; Meaghan Kall; Samir Bhatt; Paula Blomquist; Asad Zaidi; Erik Volz; Nurin Abdul Aziz; Katie Harman; Sebastian Funk; Sam Abbott; Russell Hope; Andre Charlett; Meera Chand; Azra C Ghani; Shaun R Seaman; Gavin Dabrera; Daniela De Angelis; Anne M Presanis; Simon Thelwall
Journal:  Lancet       Date:  2022-03-16       Impact factor: 202.731

Review 9.  Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis.

Authors:  Anuraag Jena; Shubhra Mishra; Parakkal Deepak; Praveen Kumar-M; Aman Sharma; Yusuf I Patel; Nicholas A Kennedy; Alfred H J Kim; Vishal Sharma; Shaji Sebastian
Journal:  Autoimmun Rev       Date:  2021-08-30       Impact factor: 9.754

10.  COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation.

Authors:  Raffi Lev-Tzion; Gili Focht; Rona Lujan; Adi Mendelovici; Chagit Friss; Shira Greenfeld; Revital Kariv; Amir Ben-Tov; Eran Matz; Daniel Nevo; Yuval Barak-Corren; Iris Dotan; Dan Turner
Journal:  Clin Gastroenterol Hepatol       Date:  2021-12-23       Impact factor: 13.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.